Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Payers

The pandemic may transform the foundation that innovative collaborations are based on.

Partner, Health & Life Sciences, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Senior Consultant, Oliver Wyman

Executives discuss the COVID-19 financial fallout and what future subsequent peaks might look like for health systems.

Market dynamics are ripe for M&A activity. But before being enticed by a mirage, leaders must revisit old lessons.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

We must focus on diligence and safety, and balance that with maintaining as much normalcy as possible.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

A model of payment transformation in Southeast Michigan is gaining traction.

Editor, Health & Life Sciences, Oliver Wyman
Senior Vice President, Health Care Value, BCBSM
Senior Vice President, Network and Provider Partnerships, BCBSM

Insights in your inbox

Subscribe

Here's how we did on last year's predictions and what emerging trends to expect next.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Manager, Health & Life Sciences, Oliver Wyman

In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

How New Price Transparency Rules May Impact Payers and Providers

Immediate considerations for the industry.

Principal, Health & Life Sciences, Oliver Wyman
Global Head, Health Services, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting

New competitors in healthcare are multiplying and scaling. But what will it take to win?

Director of Innovation, Atrium Health

Quality, not quantity, will drive the next wave of partnerships and product launches.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe